Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer

SIMPLE SUMMARY: The high recurrence risk and poor prognosis of metastatic endometrial cancer are the main focus of interventional therapy. In view of this, we established in vitro and in vivo metastasis models and explored the underlying mechanisms of the epithelial-mesenchymal transition (EMT) proc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Chen, Hsin-Yuan, Chiang, Yi-Fen, Huang, Jia-Syuan, Huang, Tsui-Chin, Shih, Yin-Hwa, Wang, Kai-Lee, Ali, Mohamed, Hong, Yong-Han, Shieh, Tzong-Ming, Hsia, Shih-Min
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8001359/
https://ncbi.nlm.nih.gov/pubmed/33799801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061236
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak